帕金森病病因和甲基胺滥用的共同点
Bruno Vincent1, Mayuri Shukla2
1Institute of Molecular and Cellular Pharmacology, Laboratory of Excellence DistALZ, Université Côte d'Azur, INSERM, CNRS, Sophia-Antipolis, 06560, Valbonne, France.
Current neuropharmacology
|September 11, 2023
概括
甲基胺滥用正在增加,可能导致像帕金森氏症这样的神经退行性疾病. 慢性使用与帕金森病共享有毒性机制,包括多巴胺破坏和神经炎症.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 神经学 神经学
背景情况:
- 在过去的十年中,在全球范围内,甲基胺滥用和相关死亡率翻了一番.
- 滥用甲基胺会导致严重的神经毒性和神经行为影响.
- 长期使用甲基胺会增加神经退行性疾病的风险.
研究的目的:
- 审查将甲基胺滥用与帕金森病联系在一起的遗传和分子机制.
- 为了说明甲基胺中毒如何可能导致帕金森病类似的病理.
主要方法:
- 关于滥用甲基胺和帕金森病的研究的综合文献综述.
- 分析共享的有毒致病机制,遗传联系和分子通路.
主要成果:
- 甲基胺诱导的神经退行包括多巴胺平衡的改变和α-synuclein聚合.
- 共同的病理机制包括线粒体功能障碍,氧化应激,神经炎症和减少的神经发生.
- 甲基胺暴露和帕金森病之间存在结构和遗传联系.
结论:
- 甲基胺滥用与帕金森病具有重要的病理机制.
- 甲胺中毒可以导致帕金森病类似的病理和帕金森症.
- 了解这些联系对于解决甲基胺滥用的神经退行性后果至关重要.
相关概念视频
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Drug Abuse and Addiction: Pharmacological Phenomena
507
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
507
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
230
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
230
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
737
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
737


